Damon Runyon News

October 29, 2020
New Discoveries


Many cancer immunotherapies, drugs that activate a patient’s immune system, have emerged in recent years, but none are universally effective. To address this shortcoming, Clinical Investigator Anusha Kalbasi, MD, and colleagues at the University of California Los Angeles found a drug that activates the body's natural defenses by behaving like a virus and may uncloak certain stealthy melanoma tumors, so they can be better targeted by immunotherapy.


October 23, 2020
Latest News

The Damon Runyon-Jake Wetchler Award for Pediatric Innovation is given annually to a third-year Damon Runyon Fellow whose research has the greatest potential to impact the prevention, diagnosis, or treatment of pediatric cancer. This year, Damon Runyon Fellow Dian Yang, PhD, at the Whitehead Institute for Biomedical Research received this special award.


October 21, 2020
Awards and Honors

Five alumni were elected to the National Academy of Medicine, bringing the total number of Damon Runyon scientists who are members to 37. Membership is considered to be one of the highest honors in the medical field and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.  


October 20, 2020
Latest News

Six months after laboratories were shuttered due to COVID-19, most of our affected Damon Runyon scientists have restarted their research with limited hours in the lab. Often, this means working in shifts either early mornings, late nights, or on weekends to maintain social distancing guidelines.


October 20, 2020
Latest News

When Anthony and Lauren Terebetsky took their 7-year-old son, Ryan, to the hospital for blood tests, they were thinking about dinner, Ryan’s homework, their daughter starting spring softball, his job at the firehouse and hers as a teacher—not a life changing diagnosis.


October 15, 2020
New Discovery

Former Damon Runyon Innovator Guillem Pratx, PhD, and colleagues at Stanford University have devised a way to use a common imaging technology called positron emission tomography, or PET, to watch the movement of a single cell injected into a laboratory mouse in real time. 


October 15, 2020
New Discovery

In developing a treatment plan for a patient, doctors rely on genetic tests on biopsied tumors in bulk rather than individual cells, which fails to capture the full extent of cellular diversity within tumors. A more complete picture of what is happening in a lung cancer tumor could yield clues for effective therapies that may benefit patients. 


October 8, 2020
Awards and Honors


Seven Damon Runyon scientists are recipients of the National Institutes of Health's High-Risk, High-Reward Research awards that will fund highly innovative and unusually impactful biomedical research proposed by extraordinarily creative scientists.


October 7, 2020
Latest News

Though the Runyon 5K, like so many things, looked a little different this year than it has in the past, participants were undaunted by the transition to a virtual race. Between August 24 and October 4, more than 450 participants walked, ran, hiked, or biked a 5K along a course of their choosing to raise funds and awareness for the Damon Runyon Cancer Research Foundation.


October 6, 2020
Blog


Damon Runyon Fellow Tikvah K. Hayes, PhD, of the Dana-Farber Cancer Institute and Harvard Medical School, discusses the importance of creating a more diverse environment in STEM careers so that the next generation of under represented researchers will have mentors and colleagues who can better guide them through their shared experiences.